2 unknown, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Recruiting 1 |
Follow Tarapeutics Science Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TR128 in Patients With Advanced Solid Tumors TR128 - Advanced Solid Tumor | Phase 1 | Unknown | Tarapeutics Science Inc. | 50 | 2024-02-23 | 2024-05-14 |
| TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors TR115 - Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory | Phase 1 | Unknown | Tarapeutics Science Inc. | 26 | 2023-04-23 | 2024-05-14 |
| TR64 in Patients With Advanced Solid Tumors TR64 - Advanced Solid Tumor | Phase 1 | Recruiting | Tarapeutics Science Inc. | 19 | 2023-01-12 | 2024-05-14 |
Lymphoma, Non-Hodgkin (1) · Recurrence (1)
China (3)
Funan Liu, MD, PhD (1) · Huan Zhou, PhD (1) · Jie Jin, MD, PhD (1) · Lin Shen, MD, PhD (1)